Ticagrelor vs. clopidogrel in patients with non-ST-elevation acute coronary syndrome with or without revascularization: results from the PLATO trial

AIMS: The optimal platelet inhibition strategy for ACS patients managed without revascularization is unknown. We aimed to evaluate efficacy and safety of ticagrelor vs. clopidogrel in the non-ST-elevation acute coronary syndrome (NSTE-ACS) subgroup of the PLATO trial, in the total cohort, and in the...

Descripción completa

Detalles Bibliográficos
Autores principales: Lindholm, Daniel, Varenhorst, Christoph, Cannon, Christopher P, Harrington, Robert A, Himmelmann, Anders, Maya, Juan, Husted, Steen, Steg, Philippe Gabriel, Cornel, Jan H, Storey, Robert F, Stevens, Susanna R, Wallentin, Lars, James, Stefan K
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2014
Materias:
Clinical Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4132637/
https://www.ncbi.nlm.nih.gov/pubmed/24727884
http://dx.doi.org/10.1093/eurheartj/ehu160

Ejemplares similares

Ejemplares similares